nodes	percent_of_prediction	percent_of_DWPC	metapath
Levobupivacaine—Dysaesthesia—Fluorouracil—head and neck cancer	0.0253	0.0258	CcSEcCtD
Levobupivacaine—Slurred speech—Fluorouracil—head and neck cancer	0.0245	0.025	CcSEcCtD
Levobupivacaine—Ileus—Vinblastine—head and neck cancer	0.0235	0.024	CcSEcCtD
Levobupivacaine—Neurotoxicity—Docetaxel—head and neck cancer	0.0204	0.0208	CcSEcCtD
Levobupivacaine—Numbness—Vinblastine—head and neck cancer	0.0201	0.0205	CcSEcCtD
Levobupivacaine—Lidocaine—EGFR—head and neck cancer	0.0201	1	CrCbGaD
Levobupivacaine—Sensory loss—Vinblastine—head and neck cancer	0.0192	0.0196	CcSEcCtD
Levobupivacaine—Extravasation—Vinblastine—head and neck cancer	0.0191	0.0195	CcSEcCtD
Levobupivacaine—Dysaesthesia—Docetaxel—head and neck cancer	0.0183	0.0186	CcSEcCtD
Levobupivacaine—Prurigo—Docetaxel—head and neck cancer	0.0171	0.0175	CcSEcCtD
Levobupivacaine—Pulmonary oedema—Hydroxyurea—head and neck cancer	0.0135	0.0138	CcSEcCtD
Levobupivacaine—Numbness—Fluorouracil—head and neck cancer	0.0132	0.0135	CcSEcCtD
Levobupivacaine—Sensory loss—Fluorouracil—head and neck cancer	0.0126	0.0129	CcSEcCtD
Levobupivacaine—Extravasation—Fluorouracil—head and neck cancer	0.0125	0.0128	CcSEcCtD
Levobupivacaine—Leukocytosis—Fluorouracil—head and neck cancer	0.0116	0.0119	CcSEcCtD
Levobupivacaine—Dysarthria—Fluorouracil—head and neck cancer	0.0116	0.0118	CcSEcCtD
Levobupivacaine—Ileus—Docetaxel—head and neck cancer	0.0112	0.0114	CcSEcCtD
Levobupivacaine—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.0103	0.0105	CcSEcCtD
Levobupivacaine—Rigors—Docetaxel—head and neck cancer	0.00967	0.00987	CcSEcCtD
Levobupivacaine—Euphoric mood—Fluorouracil—head and neck cancer	0.0094	0.00959	CcSEcCtD
Levobupivacaine—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00914	0.00933	CcSEcCtD
Levobupivacaine—Extravasation—Docetaxel—head and neck cancer	0.00905	0.00924	CcSEcCtD
Levobupivacaine—Bone disorder—Docetaxel—head and neck cancer	0.00874	0.00892	CcSEcCtD
Levobupivacaine—Infestation NOS—Hydroxyurea—head and neck cancer	0.0085	0.00868	CcSEcCtD
Levobupivacaine—Drowsiness—Hydroxyurea—head and neck cancer	0.0085	0.00868	CcSEcCtD
Levobupivacaine—Infestation—Hydroxyurea—head and neck cancer	0.0085	0.00868	CcSEcCtD
Levobupivacaine—Blood bilirubin increased—Docetaxel—head and neck cancer	0.00835	0.00852	CcSEcCtD
Levobupivacaine—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00833	0.0085	CcSEcCtD
Levobupivacaine—Hypoaesthesia—Vinblastine—head and neck cancer	0.00833	0.0085	CcSEcCtD
Levobupivacaine—Lethargy—Fluorouracil—head and neck cancer	0.0081	0.00827	CcSEcCtD
Levobupivacaine—Respiratory failure—Docetaxel—head and neck cancer	0.00804	0.00821	CcSEcCtD
Levobupivacaine—Osteoarthritis—Fluorouracil—head and neck cancer	0.00794	0.0081	CcSEcCtD
Levobupivacaine—Blood pressure increased—Docetaxel—head and neck cancer	0.0079	0.00806	CcSEcCtD
Levobupivacaine—Cardiac arrest—Fluorouracil—head and neck cancer	0.00755	0.00771	CcSEcCtD
Levobupivacaine—Neuropathy—Docetaxel—head and neck cancer	0.00741	0.00757	CcSEcCtD
Levobupivacaine—Lightheadedness—Docetaxel—head and neck cancer	0.00706	0.00721	CcSEcCtD
Levobupivacaine—Pulmonary oedema—Docetaxel—head and neck cancer	0.00703	0.00717	CcSEcCtD
Levobupivacaine—Muscular weakness—Fluorouracil—head and neck cancer	0.007	0.00715	CcSEcCtD
Levobupivacaine—Dysphagia—Fluorouracil—head and neck cancer	0.00686	0.007	CcSEcCtD
Levobupivacaine—Chills—Hydroxyurea—head and neck cancer	0.00685	0.00699	CcSEcCtD
Levobupivacaine—Anaemia—Vinblastine—head and neck cancer	0.00673	0.00687	CcSEcCtD
Levobupivacaine—Erythema—Hydroxyurea—head and neck cancer	0.00664	0.00678	CcSEcCtD
Levobupivacaine—Convulsion—Vinblastine—head and neck cancer	0.00631	0.00644	CcSEcCtD
Levobupivacaine—Hypertension—Vinblastine—head and neck cancer	0.00629	0.00642	CcSEcCtD
Levobupivacaine—Anaemia—Hydroxyurea—head and neck cancer	0.00614	0.00627	CcSEcCtD
Levobupivacaine—Infestation—Fluorouracil—head and neck cancer	0.00612	0.00625	CcSEcCtD
Levobupivacaine—Infestation NOS—Fluorouracil—head and neck cancer	0.00612	0.00625	CcSEcCtD
Levobupivacaine—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.006	0.00612	CcSEcCtD
Levobupivacaine—Urinary tract infection—Fluorouracil—head and neck cancer	0.00595	0.00607	CcSEcCtD
Levobupivacaine—Lethargy—Docetaxel—head and neck cancer	0.00585	0.00597	CcSEcCtD
Levobupivacaine—Convulsion—Hydroxyurea—head and neck cancer	0.00576	0.00587	CcSEcCtD
Levobupivacaine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00562	0.00573	CcSEcCtD
Levobupivacaine—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00547	0.00558	CcSEcCtD
Levobupivacaine—Oedema—Hydroxyurea—head and neck cancer	0.00542	0.00553	CcSEcCtD
Levobupivacaine—Infection—Hydroxyurea—head and neck cancer	0.00539	0.0055	CcSEcCtD
Levobupivacaine—Paraesthesia—Vinblastine—head and neck cancer	0.00534	0.00545	CcSEcCtD
Levobupivacaine—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00532	0.00543	CcSEcCtD
Levobupivacaine—Skin disorder—Hydroxyurea—head and neck cancer	0.00527	0.00537	CcSEcCtD
Levobupivacaine—Orthostatic hypotension—Docetaxel—head and neck cancer	0.00523	0.00534	CcSEcCtD
Levobupivacaine—Decreased appetite—Vinblastine—head and neck cancer	0.00517	0.00527	CcSEcCtD
Levobupivacaine—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.00516	0.00527	CcSEcCtD
Levobupivacaine—Constipation—Vinblastine—head and neck cancer	0.00508	0.00519	CcSEcCtD
Levobupivacaine—Pain—Vinblastine—head and neck cancer	0.00508	0.00519	CcSEcCtD
Levobupivacaine—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00506	0.00516	CcSEcCtD
Levobupivacaine—Dysphagia—Docetaxel—head and neck cancer	0.00495	0.00506	CcSEcCtD
Levobupivacaine—Arrhythmia—Fluorouracil—head and neck cancer	0.00491	0.00501	CcSEcCtD
Levobupivacaine—Feeling abnormal—Vinblastine—head and neck cancer	0.0049	0.005	CcSEcCtD
Levobupivacaine—Bronchospasm—Docetaxel—head and neck cancer	0.00487	0.00497	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00486	0.00496	CcSEcCtD
Levobupivacaine—Dyspnoea—Hydroxyurea—head and neck cancer	0.00483	0.00493	CcSEcCtD
Levobupivacaine—Somnolence—Hydroxyurea—head and neck cancer	0.00482	0.00492	CcSEcCtD
Levobupivacaine—Erythema—Fluorouracil—head and neck cancer	0.00478	0.00488	CcSEcCtD
Levobupivacaine—Dyspepsia—Hydroxyurea—head and neck cancer	0.00477	0.00487	CcSEcCtD
Levobupivacaine—Decreased appetite—Hydroxyurea—head and neck cancer	0.00471	0.00481	CcSEcCtD
Levobupivacaine—Abdominal pain—Vinblastine—head and neck cancer	0.0047	0.0048	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00468	0.00478	CcSEcCtD
Levobupivacaine—Pain—Hydroxyurea—head and neck cancer	0.00464	0.00473	CcSEcCtD
Levobupivacaine—Constipation—Hydroxyurea—head and neck cancer	0.00464	0.00473	CcSEcCtD
Levobupivacaine—Vision blurred—Fluorouracil—head and neck cancer	0.00451	0.0046	CcSEcCtD
Levobupivacaine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00447	0.00456	CcSEcCtD
Levobupivacaine—Anaemia—Fluorouracil—head and neck cancer	0.00442	0.00451	CcSEcCtD
Levobupivacaine—Infestation—Docetaxel—head and neck cancer	0.00442	0.00451	CcSEcCtD
Levobupivacaine—Infestation NOS—Docetaxel—head and neck cancer	0.00442	0.00451	CcSEcCtD
Levobupivacaine—Hypersensitivity—Vinblastine—head and neck cancer	0.00438	0.00447	CcSEcCtD
Levobupivacaine—Neuropathy peripheral—Docetaxel—head and neck cancer	0.00433	0.00442	CcSEcCtD
Levobupivacaine—Body temperature increased—Hydroxyurea—head and neck cancer	0.00429	0.00437	CcSEcCtD
Levobupivacaine—Asthenia—Vinblastine—head and neck cancer	0.00427	0.00435	CcSEcCtD
Levobupivacaine—Convulsion—Fluorouracil—head and neck cancer	0.00414	0.00423	CcSEcCtD
Levobupivacaine—Diarrhoea—Vinblastine—head and neck cancer	0.00407	0.00415	CcSEcCtD
Levobupivacaine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00399	0.00408	CcSEcCtD
Levobupivacaine—Hypoaesthesia—Docetaxel—head and neck cancer	0.00395	0.00403	CcSEcCtD
Levobupivacaine—Confusional state—Fluorouracil—head and neck cancer	0.00394	0.00402	CcSEcCtD
Levobupivacaine—Dizziness—Vinblastine—head and neck cancer	0.00393	0.00401	CcSEcCtD
Levobupivacaine—Oedema peripheral—Docetaxel—head and neck cancer	0.00391	0.00399	CcSEcCtD
Levobupivacaine—Oedema—Fluorouracil—head and neck cancer	0.0039	0.00398	CcSEcCtD
Levobupivacaine—Anaphylactic shock—Fluorouracil—head and neck cancer	0.0039	0.00398	CcSEcCtD
Levobupivacaine—Asthenia—Hydroxyurea—head and neck cancer	0.00389	0.00397	CcSEcCtD
Levobupivacaine—Infection—Fluorouracil—head and neck cancer	0.00388	0.00396	CcSEcCtD
Levobupivacaine—Nervous system disorder—Fluorouracil—head and neck cancer	0.00383	0.00391	CcSEcCtD
Levobupivacaine—Tachycardia—Fluorouracil—head and neck cancer	0.00381	0.00389	CcSEcCtD
Levobupivacaine—Vomiting—Vinblastine—head and neck cancer	0.00378	0.00386	CcSEcCtD
Levobupivacaine—Headache—Vinblastine—head and neck cancer	0.00372	0.0038	CcSEcCtD
Levobupivacaine—Diarrhoea—Hydroxyurea—head and neck cancer	0.00371	0.00379	CcSEcCtD
Levobupivacaine—Flushing—Docetaxel—head and neck cancer	0.00368	0.00376	CcSEcCtD
Levobupivacaine—Cardiac disorder—Docetaxel—head and neck cancer	0.00368	0.00376	CcSEcCtD
Levobupivacaine—Hypotension—Fluorouracil—head and neck cancer	0.00365	0.00372	CcSEcCtD
Levobupivacaine—Dizziness—Hydroxyurea—head and neck cancer	0.00359	0.00366	CcSEcCtD
Levobupivacaine—Chills—Docetaxel—head and neck cancer	0.00356	0.00363	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00356	0.00363	CcSEcCtD
Levobupivacaine—Arrhythmia—Docetaxel—head and neck cancer	0.00354	0.00361	CcSEcCtD
Levobupivacaine—Nausea—Vinblastine—head and neck cancer	0.00353	0.0036	CcSEcCtD
Levobupivacaine—Insomnia—Fluorouracil—head and neck cancer	0.00353	0.0036	CcSEcCtD
Levobupivacaine—Paraesthesia—Fluorouracil—head and neck cancer	0.0035	0.00358	CcSEcCtD
Levobupivacaine—Dyspnoea—Fluorouracil—head and neck cancer	0.00348	0.00355	CcSEcCtD
Levobupivacaine—Mental disorder—Docetaxel—head and neck cancer	0.00347	0.00354	CcSEcCtD
Levobupivacaine—Somnolence—Fluorouracil—head and neck cancer	0.00347	0.00354	CcSEcCtD
Levobupivacaine—Malnutrition—Docetaxel—head and neck cancer	0.00345	0.00352	CcSEcCtD
Levobupivacaine—Erythema—Docetaxel—head and neck cancer	0.00345	0.00352	CcSEcCtD
Levobupivacaine—Vomiting—Hydroxyurea—head and neck cancer	0.00345	0.00352	CcSEcCtD
Levobupivacaine—Dyspepsia—Fluorouracil—head and neck cancer	0.00344	0.00351	CcSEcCtD
Levobupivacaine—Headache—Hydroxyurea—head and neck cancer	0.0034	0.00347	CcSEcCtD
Levobupivacaine—Decreased appetite—Fluorouracil—head and neck cancer	0.00339	0.00346	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00337	0.00344	CcSEcCtD
Levobupivacaine—Back pain—Docetaxel—head and neck cancer	0.00334	0.00341	CcSEcCtD
Levobupivacaine—Pain—Fluorouracil—head and neck cancer	0.00334	0.00341	CcSEcCtD
Levobupivacaine—Muscle spasms—Docetaxel—head and neck cancer	0.00332	0.00339	CcSEcCtD
Levobupivacaine—Nausea—Hydroxyurea—head and neck cancer	0.00322	0.00329	CcSEcCtD
Levobupivacaine—Feeling abnormal—Fluorouracil—head and neck cancer	0.00322	0.00328	CcSEcCtD
Levobupivacaine—Anaemia—Docetaxel—head and neck cancer	0.00319	0.00326	CcSEcCtD
Levobupivacaine—Urticaria—Fluorouracil—head and neck cancer	0.0031	0.00316	CcSEcCtD
Levobupivacaine—Syncope—Docetaxel—head and neck cancer	0.0031	0.00316	CcSEcCtD
Levobupivacaine—Body temperature increased—Fluorouracil—head and neck cancer	0.00309	0.00315	CcSEcCtD
Levobupivacaine—Palpitations—Docetaxel—head and neck cancer	0.00305	0.00311	CcSEcCtD
Levobupivacaine—Loss of consciousness—Docetaxel—head and neck cancer	0.00303	0.0031	CcSEcCtD
Levobupivacaine—Cough—Docetaxel—head and neck cancer	0.00301	0.00307	CcSEcCtD
Levobupivacaine—Convulsion—Docetaxel—head and neck cancer	0.00299	0.00305	CcSEcCtD
Levobupivacaine—Hypertension—Docetaxel—head and neck cancer	0.00298	0.00304	CcSEcCtD
Levobupivacaine—Arthralgia—Docetaxel—head and neck cancer	0.00294	0.003	CcSEcCtD
Levobupivacaine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00292	0.00298	CcSEcCtD
Levobupivacaine—Hypersensitivity—Fluorouracil—head and neck cancer	0.00288	0.00293	CcSEcCtD
Levobupivacaine—Confusional state—Docetaxel—head and neck cancer	0.00284	0.0029	CcSEcCtD
Levobupivacaine—Anaphylactic shock—Docetaxel—head and neck cancer	0.00282	0.00287	CcSEcCtD
Levobupivacaine—Oedema—Docetaxel—head and neck cancer	0.00282	0.00287	CcSEcCtD
Levobupivacaine—Infection—Docetaxel—head and neck cancer	0.0028	0.00286	CcSEcCtD
Levobupivacaine—Shock—Docetaxel—head and neck cancer	0.00277	0.00283	CcSEcCtD
Levobupivacaine—Nervous system disorder—Docetaxel—head and neck cancer	0.00276	0.00282	CcSEcCtD
Levobupivacaine—Pruritus—Fluorouracil—head and neck cancer	0.00276	0.00282	CcSEcCtD
Levobupivacaine—Tachycardia—Docetaxel—head and neck cancer	0.00275	0.00281	CcSEcCtD
Levobupivacaine—Skin disorder—Docetaxel—head and neck cancer	0.00274	0.00279	CcSEcCtD
Levobupivacaine—Diarrhoea—Fluorouracil—head and neck cancer	0.00267	0.00273	CcSEcCtD
Levobupivacaine—Hypotension—Docetaxel—head and neck cancer	0.00263	0.00269	CcSEcCtD
Levobupivacaine—Dizziness—Fluorouracil—head and neck cancer	0.00258	0.00263	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00257	0.00262	CcSEcCtD
Levobupivacaine—Insomnia—Docetaxel—head and neck cancer	0.00255	0.0026	CcSEcCtD
Levobupivacaine—Paraesthesia—Docetaxel—head and neck cancer	0.00253	0.00258	CcSEcCtD
Levobupivacaine—Dyspnoea—Docetaxel—head and neck cancer	0.00251	0.00256	CcSEcCtD
Levobupivacaine—Somnolence—Docetaxel—head and neck cancer	0.0025	0.00256	CcSEcCtD
Levobupivacaine—Vomiting—Fluorouracil—head and neck cancer	0.00248	0.00253	CcSEcCtD
Levobupivacaine—Dyspepsia—Docetaxel—head and neck cancer	0.00248	0.00253	CcSEcCtD
Levobupivacaine—Decreased appetite—Docetaxel—head and neck cancer	0.00245	0.0025	CcSEcCtD
Levobupivacaine—Headache—Fluorouracil—head and neck cancer	0.00245	0.0025	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00243	0.00248	CcSEcCtD
Levobupivacaine—Constipation—Docetaxel—head and neck cancer	0.00241	0.00246	CcSEcCtD
Levobupivacaine—Pain—Docetaxel—head and neck cancer	0.00241	0.00246	CcSEcCtD
Levobupivacaine—Feeling abnormal—Docetaxel—head and neck cancer	0.00232	0.00237	CcSEcCtD
Levobupivacaine—Nausea—Fluorouracil—head and neck cancer	0.00232	0.00237	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Docetaxel—head and neck cancer	0.0023	0.00235	CcSEcCtD
Levobupivacaine—Body temperature increased—Docetaxel—head and neck cancer	0.00223	0.00227	CcSEcCtD
Levobupivacaine—Abdominal pain—Docetaxel—head and neck cancer	0.00223	0.00227	CcSEcCtD
Levobupivacaine—Hypersensitivity—Docetaxel—head and neck cancer	0.00208	0.00212	CcSEcCtD
Levobupivacaine—Asthenia—Docetaxel—head and neck cancer	0.00202	0.00206	CcSEcCtD
Levobupivacaine—Pruritus—Docetaxel—head and neck cancer	0.00199	0.00203	CcSEcCtD
Levobupivacaine—Diarrhoea—Docetaxel—head and neck cancer	0.00193	0.00197	CcSEcCtD
Levobupivacaine—Dizziness—Docetaxel—head and neck cancer	0.00186	0.0019	CcSEcCtD
Levobupivacaine—Vomiting—Docetaxel—head and neck cancer	0.00179	0.00183	CcSEcCtD
Levobupivacaine—Headache—Docetaxel—head and neck cancer	0.00176	0.0018	CcSEcCtD
Levobupivacaine—Nausea—Docetaxel—head and neck cancer	0.00167	0.00171	CcSEcCtD
